Literature DB >> 28941802

CFTR modulates RPS27 gene expression using chloride anion as signaling effector.

Ángel G Valdivieso1, Consuelo Mori1, Mariángeles Clauzure1, Macarena Massip-Copiz1, Tomás A Santa-Coloma2.   

Abstract

In Cystic Fibrosis (CF), the impairment of the CFTR channel activity leads to a variety of alterations, including differential gene expression. However, the CFTR signaling mechanisms remain unclear. Recently, culturing IB3-1 CF cells under different intracellular Cl- concentrations ([Cl-]i), we observed several Cl--dependent genes and further characterized one of them as RPS27. Thus, we hypothesized that Cl- might act as a signaling effector for CFTR signaling. Here, to test this idea, we study RPS27 expression in T84 cells modulating the CFTR activity by using CFTR inhibitors. First, we observed that incubation of T84 cells with increasing concentrations of the CFTR inhibitors CFTR(inh)-172 or GlyH-101 determined a progressive increase in the relative [Cl-]i (using the Cl- fluorescent probe SPQ). The [Cl-]i rise was concomitant with a dose-dependent down-regulation of RPS27. These results imply that CFTR inhibition produce Cl- accumulation and that RPS27 expression can be modulated by CFTR inhibition. Therefore, Cl- behaves as a signaling effector for CFTR in the modulation of RPS27 expression. In addition, the IL-1β receptor antagonist IL1RN or the JNK inhibitor SP600125, both restored the down-regulation of RPS27 induced by CFTRinh-172, implying a role of autocrine IL-1β and JNK signaling downstream of Cl- in RPS27 modulation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autocrine; CFTR; Chloride; IL-1β; IL-1β loop; IL1RN; JNK; RPS27; SP600125; Signaling effector

Mesh:

Substances:

Year:  2017        PMID: 28941802     DOI: 10.1016/j.abb.2017.09.014

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

Review 1.  Cl- as a bona fide signaling ion.

Authors:  Benjamin P Lüscher; Laura Vachel; Ehud Ohana; Shmuel Muallem
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

2.  NLR family pyrin domain containing 3 (NLRP3) and caspase 1 (CASP1) modulation by intracellular Cl- concentration.

Authors:  Mariángeles Clauzure; Ángel G Valdivieso; Andrea V Dugour; Consuelo Mori; María M Massip-Copiz; María Á Aguilar; Verónica Sotomayor; Cristian J A Asensio; Juan M Figueroa; Tomás A Santa-Coloma
Journal:  Immunology       Date:  2021-05-02       Impact factor: 7.215

3.  N-acetyl cysteine reverts the proinflammatory state induced by cigarette smoke extract in lung Calu-3 cells.

Authors:  Ángel G Valdivieso; Andrea V Dugour; Verónica Sotomayor; Mariángeles Clauzure; Juan M Figueroa; Tomás A Santa-Coloma
Journal:  Redox Biol       Date:  2018-03-14       Impact factor: 11.799

4.  Ribosomal Protein S27/Metallopanstimulin-1 (RPS27) in Glioma-A New Disease Biomarker?

Authors:  Jonas Feldheim; Almuth F Kessler; Dominik Schmitt; Ellaine Salvador; Camelia M Monoranu; Julia J Feldheim; Ralf-Ingo Ernestus; Mario Löhr; Carsten Hagemann
Journal:  Cancers (Basel)       Date:  2020-04-27       Impact factor: 6.639

5.  SARS-CoV-2 nucleocapsid protein triggers hyperinflammation via protein-protein interaction-mediated intracellular Cl- accumulation in respiratory epithelium.

Authors:  Lei Chen; Wei-Jie Guan; Zhuo-Er Qiu; Jian-Bang Xu; Xu Bai; Xiao-Chun Hou; Jing Sun; Su Qu; Ze-Xin Huang; Tian-Lun Lei; Zi-Yang Huang; Jincun Zhao; Yun-Xin Zhu; Ke-Nan Ye; Zhao-Rong Lun; Wen-Liang Zhou; Nan-Shan Zhong; Yi-Lin Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-07-27

6.  Increased intracellular Cl- concentration improves airway epithelial migration by activating the RhoA/ROCK Pathway.

Authors:  Wenjie Huang; Meiling Tan; Yue Wang; Lei Liu; Yan Pan; Jingjing Li; Mingxing Ouyang; Chunjiao Long; Xiangping Qu; Huijun Liu; Chi Liu; Jia Wang; Linhong Deng; Yang Xiang; Xiaoqun Qin
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.